ClinicalTrials.gg
Active, not recruitingNCT05741125Updated Sep 4, 2026

Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes

An interventional study of DSME + ASE intervention (Centering Appetite) in Type 2 Diabetes and Binge Eating, sponsored by University of North Carolina, Chapel Hill. Active, not recruiting at 2 sites in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Diabetes Mellitus, Type 2 by University of North Carolina, Chapel Hill — 1 open to participants now, 5 under way, none of them phase 3. Diabetes Mellitus, Type 2 · University of North Carolina, Chapel Hill.

Planned enrollment
10th of 15
60 · median 87
Started
2025
with 3 others
No phase
13 of 15
1 open now
Registered
11th of 15
by date

Among the 15 studies in Diabetes Mellitus, Type 2 by University of North Carolina, Chapel Hill, this one is the 10th largest by planned enrollment, is one of 4 that started in 2025, is one of 13 with no phase, and was the 11th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

1 of the 15 studies in Diabetes Mellitus, Type 2 by University of North Carolina, Chapel Hill is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Diabetes Mellitus, Type 2 by University of North Carolina, Chapel Hill, or all of them as a file.
02

Study summary

The purpose of this 6-month randomized clinical trial is to examine the feasibility of recruitment, attendance, retention, program adherence, and satisfaction of a digital application designed, Centering Appetite to improve glucose scores (HbA1c) and binge eating in African American adults with type 2 diabetes. Intervention participants will receive type 2 diabetes education and web-based lessons on appetite self-regulation. Participants will also receive a Fitbit to monitor daily physical activity. The investigators will follow up with participants at six months.

Read the detailed description

Using a randomized clinical trial design examine the feasibility and acceptability of a 6-month digital diabetes self-management education program plus an appetite self-regulation intervention for (n=60) African Americans (AA) with type 2 diabetes who report uncontrolled eating in North Carolina. Sixty AAs will be randomized to the Centering Appetite intervention or the control group. Over the 6 months, Centering Appetite participants will have two intervention sessions supplemented by monthly booster sessions and weekly messages related to the program. The control group will also receive two intervention sessions and weekly nutrition tutorials. The study will examine the following: recruitment feasibility, attendance/retention, treatment adherence, intervention, HbA1c, and binge eating.

03

Conditions studied

  • Type 2 Diabetes
  • Binge Eating

Keywords

  • Bing Eating
  • Type 2 Diabetes
  • African Americans
  • Digital
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Individuals are eligible if they

  • identify as a Non-Hispanic, AA
  • are over 18 years of age
  • have an A1c value > 7.5
  • have a working Smartphone
  • complete binge eating screening

Exclusion criteria

Exclusion Criteria:

Individuals will be excluded if they:

  • have major end-organ type 2 diabetes mellitus complications
  • have a history of weight loss surgery
  • are currently pregnant
  • in substance use treatment or are involved in another weight reduction program.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    DSMES + ASE intervention Appetite Self-Regulation (Centering Appetite)

    The Diabetes Self-Management Education and Support (DSMES) + Appetite Self-Regulation (ASE) intervention includes two, 45-60-minute group sessions delivered via telehealth. These sessions will enable participants to relearn their stomach's hunger and fullness signals and monitor their appetite. Participants will also learn strategies for glucose monitoring and carbohydrate management. Monthly booster sessions will be devoted to problem-solving, addressing barriers to emotion management, and self-monitoring type 2 diabetes mellitus symptoms. Participants will also receive weekly lessons with interactive activities delivered via a digital app.

    Behavioral: DSME + ASE intervention (Centering Appetite)

  • No intervention
    Control

    Control group participants will attend two remotely delivered DSMES sessions that will offer content commonly. They will also receive weekly emails providing content from the American Association of Diabetes Educators.

Interventions

  • BehavioralDSME + ASE intervention (Centering Appetite)

    The intervention will enable participants to relearn their stomach's hunger and fullness signals and monitor their appetite. Participants will also learn strategies for glucose monitoring and carbohydrate management. Monthly booster sessions will be devoted to problem-solving, addressing barriers to emotion management, and self-monitoring type 2 diabetes mellitus symptoms. Participants will also receive weekly lessons with interactive activities delivered via a digital app.

    Also known as: Improving Appetite Self-Regulation in African American Adults with Type 2 Diabetes

06

What researchers measure

Primary outcomes

  1. Feasibility (Recruitment): The Percentage of Participants Who Were Eligible and Enrolled in the Study at Baseline

    The number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.

    Time frame: Baseline

  2. Feasibility (Recruitment): The Percentage of Participants Who Were Eligible and Enrolled in the Study at Month 6

    The number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.

    Time frame: Month 6

  3. Feasibility (Attendance): The Percentage of Participants who Enrolled and Attended Each Intervention Session

    The number of potential participants who attended intervention sessions versus the number of persons who enrolled in the study and did not attend intervention sessions.

    Time frame: Month 6

  4. Feasibility (Retention): The Percentage of Participants Retained in the Study at Month 6

    Percentage of participants retained in the study following enrollment.

    Time frame: Month 6

  5. Feasibility (Treatment Adherence): The Percentage of Participants Who Adhered to Study Protocol

    Percentage of participants who adheres to study protocol.

    Time frame: Month 6

  6. Acceptability (Satisfaction): The Percentage of Participants Who Were Satisfied with the Delivery and Content of the Intervention

    Participant satisfaction will be measured using a self-report scale at month 6. The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM). This is a 4-item scale with 1 being the lowest measure and 5 being the highest measure.

    Time frame: Month 6

Secondary outcomes

  1. Changes in HbA1C

    Participant HbA1C will be measured using a glycohemoglobin analyzer.

    Time frame: Baseline, Month 6

  2. Changes in Weight

    Participant body weight will be measured by trained research staff using a calibrated digital scale.

    Time frame: Baseline, Month 6

  3. Changes in Blood Pressures (Systolic and Diastolic pressure)

    Participant blood pressures will be measured by trained research staff using a calibrated sphygmomanometer.

    Time frame: Baseline, Month 6

  4. Changes in Binge Eating Episodes

    Participant binge eating episodes will be measured using the Binge Eating Scale (BES). This is a 16-item psychological self-assessment tool used to assess the severity of binge eating behavior. Minimum values are: 0-17 which indicates non-binge eating, and the maximum values are anything greater than 27, which indicates severe binge eating.

    Time frame: Baseline, Month 6

07

Study locations

2 sites
  • Rachel W. Goode
    Kannapolis, North Carolina 28081, United States
  • UNC Nutrition Research Institute
    Kannapolis, North Carolina 28081, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Feb 2027, 24 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 24 months is above that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 13, 2023
First posted
Feb 23, 2023
StartActual
Jan 22, 2025
Primary completionEst.
Feb 15, 2027
CompletionEst.
Mar 1, 2027
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05741125
Collaborators
American Diabetes Association
Responsible party
Sponsor
First posted
Feb 23, 2023
Start date
Jan 22, 2025
Primary completion
Feb 15, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Sep 4, 2026

Study contacts

Rachel Goode, PhD, MPH, LCSW
principal investigator · University of North Carolina at Chapel Hil

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion